<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 3972         </title>
<shortdesc>PROCUREMENT-STATE DRUG LABEL</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Robert "Bob" Rita, Nabeela Syed, Jonathan Carroll, Barbara Hernández and Harry Benton</sponsors>
</sponsor>
<lastaction>
<statusdate>1/7/2025</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>30 ILCS 500/25-210 new</reference><aliasreference></aliasreference><SynopsisText>     Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides the label shall include a list of the 100 most commonly prescribed drugs. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules.</SynopsisText></synopsis>
<actions>
<statusdate>2/17/2023</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Robert "Bob" Rita</action>
<statusdate>2/17/2023</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>2/17/2023</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>2/22/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Nabeela Syed</action>
<statusdate>2/28/2023</statusdate><chamber>House</chamber><action>Assigned to Prescription Drug Affordability &amp; Accessibility Committee</action>
<statusdate>3/6/2023</statusdate><chamber>House</chamber><action>House Committee Amendment No. 1 Filed with Clerk by Rep. Robert "Bob" Rita</action>
<statusdate>3/6/2023</statusdate><chamber>House</chamber><action>House Committee Amendment No. 1 Referred to Rules Committee</action>
<statusdate>3/6/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Jonathan Carroll</action>
<statusdate>3/6/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Barbara Hernández</action>
<statusdate>3/8/2023</statusdate><chamber>House</chamber><action>House Committee Amendment No. 1 Referred to Prescription Drug Affordability &amp; Accessibility Committee</action>
<statusdate>3/8/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Harry Benton</action>
<statusdate>3/10/2023</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>3/10/2023</statusdate><chamber>House</chamber><action>House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee</action>
<statusdate>1/7/2025</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

